Table: OncoTherapy Science -2017/18 parent results
May 11 (Reuters)-
OncoTherapy Science Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2018 Mar 31, 2017 Mar 31, 2019 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 205 mln 286 mln
(-28.3 pct) (+7.4 pct)
Operating loss 2.70 loss 2.99
Recurring loss 2.68 loss 3.00
Net loss 2.63 loss 3.00
EPS loss 17.85 yen loss 20.37 yen
Ann Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - OncoTherapy Science Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T